Springer Nature
Browse
12882_2017_444_MOESM5_ESM.docx (11.71 kB)

Additional file 5: Table S3. of Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial

Download (11.71 kB)
journal contribution
posted on 2017-01-17, 05:00 authored by Iain Macdougall, Andreas Bock, Fernando Carrera, Kai-Uwe Eckardt, Carlo Gaillard, David Van Wyck, Yvonne Meier, Sylvain Larroque, Simon Roger
Selected renal adverse events and serious adverse events (safety population). (DOCX 11 kb)

Funding

The FIND-CKD study was funded by Vifor Pharma, Glattbrugg, Switzerland. Medical writing supported was provided by a freelance medical writer funded by Vifor Pharma (C Dunstall).

History

Usage metrics

    BMC Nephrology

    Categories

    Keywords

    Chronic kidney diseaseFerinjectFerric carboxymaltoseeGFRIntravenousRenal function

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC